The company conducted the survey of 404 owners after news that the bio-pharma company Okava plans to trial a weight-loss drug for dogs that mimics the effects of weight-loss drugs like Wegovy, tapping into a potential $10 billion market.
Of the pet owners who responded, it was the younger group aged 25-34 who were most receptive to the idea of a weight-loss drug for their pet (56%).
That figure fell to 21% of 45–54-year-olds and 20% among those aged 55 and above, most of whom were probably holding up their hands in horror: "Whatever next".
Alicia Hempsted, pet insurance spokeswoman from MoneySuperMarket, said: “If GLP-1 style treatments for obesity become available for dogs in the future, it’s likely that owners will have to pay out of pocket for them, which may affect their availability."
https://www.moneysupermarket.com/pet-insurance/
Photo: www.depositphotos.com
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.